EDAP TMS SA

Listed Company

EDAPCIK 0001041934NasdaqNon-AcceleratedSmaller ReportingElectromedical & Electrotherapeutic ApparatusFRFY ends Dec 31

Period

FY 2025

Revenue

$70.53M

Net Income

$-29.25M

Total Assets

$79.00M

Equity

$19.41M

Shares Out

37.48M

Op. Cash Flow

$-16.41M

Business

EDAP TMS SA develops, manufactures, promotes and distributes advanced non-invasive ultrasound technologies for diagnosis and treatment, with a strategic focus on robotic HIFU therapy. It offers the Focal One Robotic HIFU system and related consumables, treatment‑on‑demand (RPP) and lease models, as well as lithotripter ESWL systems, surgical lasers, micro‑ultrasound imaging and associated service and maintenance contracts. Its operations are organized into three divisions: HIFU, ESWL and Distribution. The company sells primarily to hospitals, academic centers and urology clinics across Europe, the Americas, Asia and other international markets through direct sales and selected distributors.

Summary from filing dated 2025-03-27

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31
Total revenues	71	69
Total cost of sales	−41	−41
Gross profit	30	29
Research and development expenses	−10	−8
Selling and marketing expenses	−27	−27
General and administrative expenses	−18	−15
Income (loss) from operations	−25	−22
Financial (expense) income, net	−3	606,000
Foreign currency exchange gain (loss), net	−1	1
Loss before taxes	−29	−20
Income tax expense	−438,000	−313,000
Loss	−29	−21
Basic loss per share	−0.78	−0.55
Diluted loss per share	−0.78	−0.55
Basic Weighted average shares outstanding (in shares)	37	37
Diluted Weighted average shares outstanding (in shares)	37	37

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31
Cash and cash equivalents	20	31	—
Current portion of net trade accounts and notes receivable	21	19	—
Other receivables	1	2	—
Inventories	13	19	—
Other assets, current portion	1	1	—
Total current assets	57	73	—
Property and equipment, net	10	8	—
Operating lease right-of-use assets	3	3	—
Intangible assets, net	2	1	—
Goodwill	3	3	—
Deposits and other non-current assets	2	2	—
Deferred tax assets	1	865,000	—
Net Trade accounts and notes receivable, non-current	546,000	—	—
Total assets	79	89	—
Trade accounts and notes payable	12	13	—
Deferred revenues, current portion	7	7	—
Social security and other payroll withholdings taxes	2	2	—
Employee absences compensation	1	1	—
Income taxes payable	193,000	−8,000	—
Other accrued liabilities	5	6	—
Short-term borrowings	6	6	—
Current obligations under finance leases	182,000	175,000	—
Current portion of operating lease obligations	1	1	—
Current portion of long-term debt	2	3	—
Total current liabilities	37	39	—
Deferred revenues, non-current	966,000	372,000	—
Obligations under finance leases	355,000	364,000	—
Operating lease obligations, non-current	2	2	—
Long-term debt, non-current	16	2	—
Other long-term liabilities	3	3	—
Total liabilities	60	47	—
Common stock at 0.13, or $0.15 at closing rate par value; 37,751,519 shares authorized and issued and 37,481,986 shares outstanding at December 31, 2025 0.13 or $0.14 at closing rate par value 37,661,619 shares authorized and issued and 37,392,086 shares outstanding at December 31, 2024	6	6	—
Additional paid-in capital	151	149	—
Accumulated deficit	−129	−99	—
Cumulative other comprehensive loss	−8	−12	—
Treasury stock, at cost 269,533 shares at December 31, 2025 and 269,533 shares at December 31, 2024	−1	−1	—
Total shareholders' equity	19	42	63
Total liabilities and shareholders' equity	79	89	—

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31
Net loss	−29	−21
Depreciation and amortization	3	3
Share based compensation	3	4
Change in allowances for doubtful accounts & slow-moving inventories	919,000	1
Change in Fair Value on EIB Warrants and Loan amortization	3	—
Change in long-term provisions	−140,000	187,000
Net capital loss on disposals of assets	529,000	558,000
Deferred tax expense (benefit)	−231,000	−105,000
Operating cash flow before changes in working capital	−19	−13
Decrease (Increase) in trade accounts and notes and other receivables	−567,000	−150,000
Decrease (Increase) in inventories	7	−4
Decrease (Increase) in other assets	72,000	−620,000
(Decrease) Increase in trade accounts and notes payable	−3	1
(Decrease) Increase in accrued expenses, other current liabilities	−462,000	2
Net change in operating assets and liabilities	3	−2
Net cash generated by (used in) operating activities	−16	−15
Additions to capitalized assets produced by the Company	−4	−3
Acquisitions of property and equipment	−1	−1
Acquisitions of intangible assets	−832,000	−249,000
Decrease (Increase) of other financial assets	0	—
Decrease (Increase) in deposits and guarantees	43,000	−21,000
Net cash generated by (used in) investing activities	−6	−4
Proceeds from stock-option exercise	—	125,000
Proceeds from long term borrowings, net of financing costs	12	3
Repayment of long term borrowings	−3	−2
Repayment of obligations under financing leases	−205,000	−251,000
Increase (decrease) in bank overdrafts and short-term borrowings	−883,000	4
Net cash generated by (used in) financing activities	9	5
Net effect of exchange rate changes on cash and cash equivalents	3	−3
Net increase (decrease) in cash and cash equivalents	−11	−17

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro